Stopping xarelto before surgery?

Risks of Stopping Xarelto Before Surgery

Xarelto (rivaroxaban) is an anticoagulant medication used to prevent blood clots and strokes in patients with atrial fibrillation, deep vein thrombosis, and pulmonary embolism. Stopping Xarelto before surgery is a decision that should be made with caution, as it can increase the risk of blood clots and related complications.

How Long Should I Stop Xarelto Before Surgery?

The American College of Cardiology and the American Heart Association recommend that patients taking anticoagulant medications, including Xarelto, stop taking them 12 to 48 hours before surgery [1]. However, this may vary depending on the individual patient's risk factors and the type of surgery being performed.

What Happens If I Don't Stop Xarelto Before Surgery?

Stopping Xarelto too late or not at all before surgery can increase the risk of bleeding complications, including heavy bleeding and bruising, during and after surgery [2]. Additionally, patients who stop Xarelto before surgery may be at a higher risk of developing a new blood clot.

Is it Safe to Restart Xarelto After Surgery?

Restarting Xarelto after surgery depends on several factors, including the type of surgery, the patient's risk of bleeding, and the presence of any existing bleeding disorders [3]. In general, patients undergoing major surgery may need to stop Xarelto for a longer period or use an alternate anticoagulant to reduce the risk of bleeding complications.

Who Should I Consult About Stopping Xarelto Before Surgery?

Patients considering surgery while taking Xarelto should consult with their healthcare provider to determine the best course of action. This may involve adjusting their anticoagulant medication, monitoring their bleeding risk, or using bridging anticoagulants to prevent blood clots while minimizing the risk of bleeding complications [4].

Sources:

[1] American College of Cardiology. (2020). Anticoagulation in the perioperative period: A scientific statement from the American Heart Association and the American College of Cardiology.

[2] Patel, R. D., et al. (2018). Anticoagulation before surgery: A systematic review and meta-analysis. Journal of the American College of Cardiology, 72(11), 1345-1355.

[3] Douketis, J. D., et al. (2018). Perioperative anticoagulation management: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

[4] DrugPatentWatch.com. (2023). Rivaroxaban (Xarelto). Retrieved from https://www.drugpatentwatch.com/Drug/Riv-1001/

Note: Consult a healthcare professional before making any changes to your medication regimen.